학술논문
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study
Document Type
Article
Author
Schuster, Michael; Zijlstra, Josée; Casasnovas, Rene-Olivier; Vermaat, Joost S.P; Kalakonda, Nagesh; Goy, Andre; Choquet, Sylvain; Neste, Eric Van Den; Hill, Brian; Thieblemont, Catherine; Cavallo, Federica; De la Cruz, Fatima; Kuruvilla, John; Hamad, Nada; Jaeger, Ulrich; Caimi, Paolo; Gurion, Ronit; Warzocha, Krzysztof; Bakhshi, Sameer; Sancho, Juan-Manuel; Follows, George; Egyed, Miklos; Offner, Fritz; Vassilakopoulos, Theodoros; Samal, Priyanka; Ku, Matthew; Ma, Xiwen; Corona, Kelly; Chamoun, Kamal; Shah, Jatin; Shacham, Sharon; Kauffman, Michael G.; Canales, Miguel; Maerevoet, Marie
Source
In Clinical Lymphoma, Myeloma and Leukemia July 2022 22(7):483-494
Subject
Language
ISSN
2152-2650